Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 6.45491967 |
2 | translational termination (GO:0006415) | 6.17938317 |
3 | ribosomal small subunit biogenesis (GO:0042274) | 5.79937550 |
4 | ribosomal small subunit assembly (GO:0000028) | 5.74212483 |
5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.39659950 |
6 | ribosomal large subunit biogenesis (GO:0042273) | 5.28784702 |
7 | protein targeting to ER (GO:0045047) | 5.24585569 |
8 | cotranslational protein targeting to membrane (GO:0006613) | 5.22980452 |
9 | translational elongation (GO:0006414) | 5.09053021 |
10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.99327992 |
11 | protein localization to endoplasmic reticulum (GO:0070972) | 4.86411742 |
12 | viral life cycle (GO:0019058) | 4.77470705 |
13 | cellular protein complex disassembly (GO:0043624) | 4.59350638 |
14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.55754925 |
15 | maturation of SSU-rRNA (GO:0030490) | 4.34455244 |
16 | translational initiation (GO:0006413) | 4.29710746 |
17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.28501333 |
18 | GDP-mannose metabolic process (GO:0019673) | 4.01956361 |
19 | negative regulation of cell size (GO:0045792) | 3.92510964 |
20 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.87342145 |
21 | protein complex disassembly (GO:0043241) | 3.85415965 |
22 | natural killer cell activation involved in immune response (GO:0002323) | 3.78801763 |
23 | NIK/NF-kappaB signaling (GO:0038061) | 3.70020296 |
24 | cytidine metabolic process (GO:0046087) | 3.66604658 |
25 | cytidine catabolic process (GO:0006216) | 3.66604658 |
26 | cytidine deamination (GO:0009972) | 3.66604658 |
27 | macromolecular complex disassembly (GO:0032984) | 3.64303623 |
28 | daunorubicin metabolic process (GO:0044597) | 3.58190049 |
29 | polyketide metabolic process (GO:0030638) | 3.58190049 |
30 | doxorubicin metabolic process (GO:0044598) | 3.58190049 |
31 | regulation of defense response to virus by host (GO:0050691) | 3.56311800 |
32 | base-excision repair, AP site formation (GO:0006285) | 3.54863473 |
33 | cellular extravasation (GO:0045123) | 3.45293667 |
34 | protein targeting to membrane (GO:0006612) | 3.40858826 |
35 | positive regulation of histone deacetylation (GO:0031065) | 3.35856959 |
36 | positive regulation of chemokine secretion (GO:0090197) | 3.29598086 |
37 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.27660680 |
38 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.26564018 |
39 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.21678054 |
40 | desmosome organization (GO:0002934) | 3.20656751 |
41 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.18586335 |
42 | DNA deamination (GO:0045006) | 3.16617802 |
43 | mRNA catabolic process (GO:0006402) | 3.15288138 |
44 | translation (GO:0006412) | 3.13372751 |
45 | fructose metabolic process (GO:0006000) | 3.12503780 |
46 | negative regulation of B cell apoptotic process (GO:0002903) | 3.11103965 |
47 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.08282312 |
48 | endothelium development (GO:0003158) | 3.04899247 |
49 | negative regulation of defense response to virus (GO:0050687) | 3.03420278 |
50 | anatomical structure regression (GO:0060033) | 3.01464094 |
51 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.93066857 |
52 | regulation of chemokine secretion (GO:0090196) | 2.91264604 |
53 | RNA catabolic process (GO:0006401) | 2.90679490 |
54 | positive regulation of defense response to virus by host (GO:0002230) | 2.87707236 |
55 | superoxide anion generation (GO:0042554) | 2.87417004 |
56 | leukocyte degranulation (GO:0043299) | 2.79561649 |
57 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.79502387 |
58 | tRNA modification (GO:0006400) | 2.77858995 |
59 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.77788719 |
60 | Peyers patch development (GO:0048541) | 2.76546504 |
61 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.76546504 |
62 | positive regulation of protein deacetylation (GO:0090312) | 2.75479293 |
63 | positive regulation of B cell differentiation (GO:0045579) | 2.69688034 |
64 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.69579396 |
65 | B cell mediated immunity (GO:0019724) | 2.69031433 |
66 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.68792895 |
67 | DNA replication checkpoint (GO:0000076) | 2.67709966 |
68 | proteasome assembly (GO:0043248) | 2.67010689 |
69 | pentose metabolic process (GO:0019321) | 2.66999938 |
70 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.66997879 |
71 | transcription from mitochondrial promoter (GO:0006390) | 2.66318708 |
72 | regulation of B cell apoptotic process (GO:0002902) | 2.66230135 |
73 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.62912726 |
74 | DNA topological change (GO:0006265) | 2.62339610 |
75 | lipoxygenase pathway (GO:0019372) | 2.62178221 |
76 | telomere maintenance via recombination (GO:0000722) | 2.59922321 |
77 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.59024519 |
78 | proline biosynthetic process (GO:0006561) | 2.56979269 |
79 | negative regulation of response to biotic stimulus (GO:0002832) | 2.55211808 |
80 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.54806451 |
81 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.53993226 |
82 | carbohydrate phosphorylation (GO:0046835) | 2.53851932 |
83 | cellular component biogenesis (GO:0044085) | 2.53612408 |
84 | positive regulation of hair cycle (GO:0042635) | 2.53492192 |
85 | positive regulation of hair follicle development (GO:0051798) | 2.53492192 |
86 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.53390188 |
87 | response to peptidoglycan (GO:0032494) | 2.53285645 |
88 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.52995286 |
89 | mitochondrial RNA metabolic process (GO:0000959) | 2.52429035 |
90 | regulation of respiratory burst (GO:0060263) | 2.51092256 |
91 | cellular response to dsRNA (GO:0071359) | 2.50729038 |
92 | regulation of B cell differentiation (GO:0045577) | 2.50607735 |
93 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.49066961 |
94 | response to type I interferon (GO:0034340) | 2.49016908 |
95 | angiogenesis involved in wound healing (GO:0060055) | 2.48575651 |
96 | rRNA processing (GO:0006364) | 2.48347066 |
97 | immunoglobulin mediated immune response (GO:0016064) | 2.47321887 |
98 | autophagic vacuole fusion (GO:0000046) | 2.46425443 |
99 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.46385567 |
100 | pentose-phosphate shunt (GO:0006098) | 2.46000804 |
101 | CENP-A containing nucleosome assembly (GO:0034080) | 2.45948181 |
102 | interferon-gamma production (GO:0032609) | 2.45236527 |
103 | pseudouridine synthesis (GO:0001522) | 2.44206977 |
104 | negative regulation of phagocytosis (GO:0050765) | 2.43350235 |
105 | meiotic chromosome segregation (GO:0045132) | 2.43148649 |
106 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.42739021 |
107 | cellular response to type I interferon (GO:0071357) | 2.42713671 |
108 | type I interferon signaling pathway (GO:0060337) | 2.42713671 |
109 | mitotic recombination (GO:0006312) | 2.42412829 |
110 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.40191570 |
111 | termination of RNA polymerase III transcription (GO:0006386) | 2.40191570 |
112 | glucose catabolic process (GO:0006007) | 2.38944442 |
113 | chromatin remodeling at centromere (GO:0031055) | 2.38595195 |
114 | rRNA metabolic process (GO:0016072) | 2.37198516 |
115 | intra-S DNA damage checkpoint (GO:0031573) | 2.35743822 |
116 | snRNA metabolic process (GO:0016073) | 2.35698366 |
117 | telomere maintenance via telomere lengthening (GO:0010833) | 2.35497922 |
118 | sphingoid metabolic process (GO:0046519) | 2.35164815 |
119 | keratinocyte proliferation (GO:0043616) | 2.34463126 |
120 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.34061688 |
121 | leukocyte aggregation (GO:0070486) | 2.33304283 |
122 | sulfur amino acid catabolic process (GO:0000098) | 2.33032001 |
123 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.32975940 |
124 | lymph node development (GO:0048535) | 2.32883615 |
125 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.32455698 |
126 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.32363584 |
127 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.31721381 |
128 | ribosome biogenesis (GO:0042254) | 2.31440509 |
129 | regulation of antigen processing and presentation (GO:0002577) | 2.29470303 |
130 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.29090201 |
131 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.29090201 |
132 | peptidyl-histidine modification (GO:0018202) | 2.28798079 |
133 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.28331255 |
134 | positive regulation of prostaglandin secretion (GO:0032308) | 2.28213128 |
135 | ncRNA 3-end processing (GO:0043628) | 2.28208191 |
136 | negative regulation of viral release from host cell (GO:1902187) | 2.27854371 |
137 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.27222191 |
138 | cellular response to zinc ion (GO:0071294) | 2.26800834 |
139 | actin nucleation (GO:0045010) | 2.26626118 |
140 | snRNA processing (GO:0016180) | 2.26241802 |
141 | DNA ligation (GO:0006266) | 2.25433667 |
142 | deoxyribose phosphate catabolic process (GO:0046386) | 2.25041390 |
143 | cellular response to exogenous dsRNA (GO:0071360) | 2.24618846 |
144 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.24504854 |
145 | deoxyribonucleotide catabolic process (GO:0009264) | 2.24309380 |
146 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.23371716 |
147 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.23213085 |
148 | natural killer cell activation (GO:0030101) | 2.22823710 |
149 | positive regulation of antigen processing and presentation (GO:0002579) | 2.22588951 |
150 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.22115099 |
151 | T cell lineage commitment (GO:0002360) | 2.21837221 |
152 | myeloid dendritic cell activation (GO:0001773) | 2.21677703 |
153 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.21422658 |
154 | positive regulation of respiratory burst (GO:0060267) | 2.21195989 |
155 | positive regulation of epidermis development (GO:0045684) | 2.21056902 |
156 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.20856007 |
157 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.20553576 |
158 | tRNA methylation (GO:0030488) | 2.20167548 |
159 | nucleotide salvage (GO:0043173) | 2.19716780 |
160 | respiratory chain complex IV assembly (GO:0008535) | 2.19543452 |
161 | definitive hemopoiesis (GO:0060216) | 2.18457324 |
162 | dendritic cell chemotaxis (GO:0002407) | 2.17615837 |
163 | positive regulation of T cell apoptotic process (GO:0070234) | 2.16996860 |
164 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.16165962 |
165 | DNA strand elongation (GO:0022616) | 2.16001919 |
166 | diol metabolic process (GO:0034311) | 2.15836692 |
167 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.15752727 |
168 | mitotic G1/S transition checkpoint (GO:0044819) | 2.15744812 |
169 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.15559500 |
170 | rRNA modification (GO:0000154) | 2.14960208 |
171 | modulation by virus of host process (GO:0019054) | 2.14718689 |
172 | pinocytosis (GO:0006907) | 2.14594602 |
173 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.14443614 |
174 | kinetochore organization (GO:0051383) | 2.13812482 |
175 | glucosamine-containing compound catabolic process (GO:1901072) | 2.13671384 |
176 | purine nucleotide salvage (GO:0032261) | 2.13652857 |
177 | positive regulation of protein homooligomerization (GO:0032464) | 2.13447434 |
178 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.13286667 |
179 | RNA methylation (GO:0001510) | 2.12885491 |
180 | metallo-sulfur cluster assembly (GO:0031163) | 2.11790360 |
181 | iron-sulfur cluster assembly (GO:0016226) | 2.11790360 |
182 | positive thymic T cell selection (GO:0045059) | 2.10733760 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.34669546 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.31183188 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.38160780 |
4 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.15799802 |
5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.10542469 |
6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.76492605 |
7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.71609783 |
8 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.54162957 |
9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.53233803 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.53122267 |
11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.51273110 |
12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.48316337 |
13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41087917 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36296502 |
15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.35856309 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35451547 |
17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.31481639 |
18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.30196688 |
19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.25409157 |
20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.15533132 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15310549 |
22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.14854443 |
23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10492388 |
24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.08886098 |
25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08676027 |
26 | P68_20966046_ChIP-Seq_HELA_Human | 2.02457252 |
27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.97653358 |
28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.97054711 |
29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.95337967 |
30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.93149147 |
31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.90112357 |
32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.89577572 |
33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87772465 |
34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85953090 |
35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.85741898 |
36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85594539 |
37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.84016576 |
38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83085984 |
39 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82702303 |
40 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.81420838 |
41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.75280747 |
42 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.73681949 |
43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73204520 |
44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.71392039 |
45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.69992007 |
46 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.69879635 |
47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69727612 |
48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68411651 |
49 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.66876238 |
50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66328757 |
51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66280338 |
52 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.66209085 |
53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62754209 |
54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.60255825 |
55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.59293406 |
56 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.59070585 |
57 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.58543564 |
58 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.58290945 |
59 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.56824035 |
60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55324712 |
61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55142883 |
62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54235840 |
63 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53794992 |
64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52026420 |
65 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.51006983 |
66 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.50605433 |
67 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50284112 |
68 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50010136 |
69 | MAF_26560356_Chip-Seq_TH1_Human | 1.49264126 |
70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47121572 |
71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.47036292 |
72 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46555763 |
73 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.46381136 |
74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45900004 |
75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45143523 |
76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44948195 |
77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44277144 |
78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.44205082 |
79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.43717146 |
80 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.40930735 |
81 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40223388 |
82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39637760 |
83 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39068135 |
84 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.38609304 |
85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38535598 |
86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36854749 |
87 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36162004 |
88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.34723613 |
89 | MYB_26560356_Chip-Seq_TH1_Human | 1.34437834 |
90 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.33657153 |
91 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.32998997 |
92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32766744 |
93 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.32431638 |
94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31844366 |
95 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.30448309 |
96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29744953 |
97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28964485 |
98 | MYB_26560356_Chip-Seq_TH2_Human | 1.27728177 |
99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27659791 |
100 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.27423485 |
101 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27031212 |
102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26835484 |
103 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26422907 |
104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26380380 |
105 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.26287470 |
106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25686425 |
107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.25055510 |
108 | MYC_22102868_ChIP-Seq_BL_Human | 1.24292234 |
109 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24165227 |
110 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.24053901 |
111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.23705081 |
112 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22739262 |
113 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22675024 |
114 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.22549856 |
115 | P300_27268052_Chip-Seq_Bcells_Human | 1.22431454 |
116 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22033524 |
117 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.21700479 |
118 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21598431 |
119 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.20004622 |
120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19869516 |
121 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18435711 |
122 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.17385228 |
123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17211264 |
124 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.16081463 |
125 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15602971 |
126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.14658552 |
127 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14045846 |
128 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13892796 |
129 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.13453854 |
130 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13225373 |
131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12535626 |
132 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11993470 |
133 | MAF_26560356_Chip-Seq_TH2_Human | 1.11471107 |
134 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11297553 |
135 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.10381246 |
136 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10125991 |
137 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09753443 |
138 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08843672 |
139 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08480756 |
140 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08479994 |
141 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07070789 |
142 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05265526 |
143 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03913265 |
144 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03913265 |
145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03764182 |
146 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98355228 |
147 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98355228 |
148 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98355228 |
149 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.95595273 |
150 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91759060 |
151 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91438747 |
152 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89121110 |
153 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87609667 |
154 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85117244 |
155 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83569760 |
156 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.83183427 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009379_abnormal_foot_pigmentation | 4.95075494 |
2 | MP0002877_abnormal_melanocyte_morpholog | 4.26343626 |
3 | MP0005451_abnormal_body_composition | 3.17327759 |
4 | MP0003941_abnormal_skin_development | 3.13213812 |
5 | MP0003828_pulmonary_edema | 2.52660249 |
6 | MP0003303_peritoneal_inflammation | 2.50582881 |
7 | MP0005083_abnormal_biliary_tract | 2.48733141 |
8 | MP0002138_abnormal_hepatobiliary_system | 2.47608929 |
9 | MP0003724_increased_susceptibility_to | 2.41244060 |
10 | MP0003763_abnormal_thymus_physiology | 2.31280256 |
11 | MP0008260_abnormal_autophagy | 2.21495461 |
12 | MP0001835_abnormal_antigen_presentation | 2.21446962 |
13 | MP0005084_abnormal_gallbladder_morpholo | 2.13088603 |
14 | MP0003436_decreased_susceptibility_to | 2.10338198 |
15 | MP0002396_abnormal_hematopoietic_system | 2.08953027 |
16 | MP0003693_abnormal_embryo_hatching | 2.00453303 |
17 | MP0002148_abnormal_hypersensitivity_rea | 1.93488046 |
18 | MP0000685_abnormal_immune_system | 1.92058872 |
19 | MP0001790_abnormal_immune_system | 1.88297277 |
20 | MP0005387_immune_system_phenotype | 1.88297277 |
21 | MP0000372_irregular_coat_pigmentation | 1.82260290 |
22 | MP0001348_abnormal_lacrimal_gland | 1.76465753 |
23 | MP0001800_abnormal_humoral_immune | 1.76122085 |
24 | MP0005671_abnormal_response_to | 1.69935789 |
25 | MP0009785_altered_susceptibility_to | 1.69635264 |
26 | MP0004381_abnormal_hair_follicle | 1.69191215 |
27 | MP0008007_abnormal_cellular_replicative | 1.65223028 |
28 | MP0002452_abnormal_antigen_presenting | 1.64366797 |
29 | MP0000490_abnormal_crypts_of | 1.62859925 |
30 | MP0002653_abnormal_ependyma_morphology | 1.59690801 |
31 | MP0010155_abnormal_intestine_physiology | 1.55394301 |
32 | MP0005000_abnormal_immune_tolerance | 1.54408221 |
33 | MP0002132_abnormal_respiratory_system | 1.54163529 |
34 | MP0005025_abnormal_response_to | 1.53096002 |
35 | MP0002420_abnormal_adaptive_immunity | 1.52871628 |
36 | MP0008995_early_reproductive_senescence | 1.52311656 |
37 | MP0008004_abnormal_stomach_pH | 1.51554242 |
38 | MP0001819_abnormal_immune_cell | 1.51537015 |
39 | MP0000015_abnormal_ear_pigmentation | 1.49864274 |
40 | MP0002928_abnormal_bile_duct | 1.49308985 |
41 | MP0002723_abnormal_immune_serum | 1.43959664 |
42 | MP0001853_heart_inflammation | 1.41674103 |
43 | MP0009333_abnormal_splenocyte_physiolog | 1.41666548 |
44 | MP0002277_abnormal_respiratory_mucosa | 1.41620535 |
45 | MP0003806_abnormal_nucleotide_metabolis | 1.40984458 |
46 | MP0001879_abnormal_lymphatic_vessel | 1.40429970 |
47 | MP0010094_abnormal_chromosome_stability | 1.40365230 |
48 | MP0003252_abnormal_bile_duct | 1.40032928 |
49 | MP0002796_impaired_skin_barrier | 1.39852179 |
50 | MP0002419_abnormal_innate_immunity | 1.39632149 |
51 | MP0009278_abnormal_bone_marrow | 1.37625522 |
52 | MP0005464_abnormal_platelet_physiology | 1.36924132 |
53 | MP0000371_diluted_coat_color | 1.35332698 |
54 | MP0003646_muscle_fatigue | 1.34186308 |
55 | MP0002098_abnormal_vibrissa_morphology | 1.33790464 |
56 | MP0005408_hypopigmentation | 1.33720810 |
57 | MP0002405_respiratory_system_inflammati | 1.31823060 |
58 | MP0002166_altered_tumor_susceptibility | 1.30859113 |
59 | MP0005645_abnormal_hypothalamus_physiol | 1.29765813 |
60 | MP0000858_altered_metastatic_potential | 1.28559264 |
61 | MP0003300_gastrointestinal_ulcer | 1.26820557 |
62 | MP0002398_abnormal_bone_marrow | 1.26554822 |
63 | MP0004957_abnormal_blastocyst_morpholog | 1.25633011 |
64 | MP0002060_abnormal_skin_morphology | 1.25388451 |
65 | MP0001873_stomach_inflammation | 1.22225676 |
66 | MP0003453_abnormal_keratinocyte_physiol | 1.22141033 |
67 | MP0002095_abnormal_skin_pigmentation | 1.21915401 |
68 | MP0005174_abnormal_tail_pigmentation | 1.20461902 |
69 | MP0000678_abnormal_parathyroid_gland | 1.19196533 |
70 | MP0009840_abnormal_foam_cell | 1.17880959 |
71 | MP0005501_abnormal_skin_physiology | 1.17539554 |
72 | MP0000716_abnormal_immune_system | 1.16444950 |
73 | MP0003111_abnormal_nucleus_morphology | 1.16423106 |
74 | MP0003045_fibrosis | 1.15985018 |
75 | MP0001216_abnormal_epidermal_layer | 1.12503646 |
76 | MP0006036_abnormal_mitochondrial_physio | 1.12392766 |
77 | MP0005076_abnormal_cell_differentiation | 1.11400470 |
78 | MP0005397_hematopoietic_system_phenotyp | 1.10585231 |
79 | MP0001545_abnormal_hematopoietic_system | 1.10585231 |
80 | MP0005670_abnormal_white_adipose | 1.09583322 |
81 | MP0004145_abnormal_muscle_electrophysio | 1.09119944 |
82 | MP0005171_absent_coat_pigmentation | 1.08940028 |
83 | MP0002006_tumorigenesis | 1.08602499 |
84 | MP0002722_abnormal_immune_system | 1.07544410 |
85 | MP0003077_abnormal_cell_cycle | 1.07303477 |
86 | MP0000689_abnormal_spleen_morphology | 1.07237500 |
87 | MP0000613_abnormal_salivary_gland | 1.06606972 |
88 | MP0003172_abnormal_lysosome_physiology | 1.06025983 |
89 | MP0004808_abnormal_hematopoietic_stem | 1.05634419 |
90 | MP0000703_abnormal_thymus_morphology | 1.05596651 |
91 | MP0005075_abnormal_melanosome_morpholog | 1.04373369 |
92 | MP0006035_abnormal_mitochondrial_morpho | 1.03437781 |
93 | MP0001661_extended_life_span | 1.03120908 |
94 | MP0002429_abnormal_blood_cell | 1.02954283 |
95 | MP0004233_abnormal_muscle_weight | 1.02787586 |
96 | MP0009931_abnormal_skin_appearance | 1.02177793 |
97 | MP0005310_abnormal_salivary_gland | 1.01827365 |
98 | MP0005330_cardiomyopathy | 1.01373901 |
99 | MP0008932_abnormal_embryonic_tissue | 1.01335550 |
100 | MP0003566_abnormal_cell_adhesion | 0.99915401 |
101 | MP0002933_joint_inflammation | 0.99613337 |
102 | MP0000750_abnormal_muscle_regeneration | 0.99507289 |
103 | MP0008058_abnormal_DNA_repair | 0.97843569 |
104 | MP0005058_abnormal_lysosome_morphology | 0.97638985 |
105 | MP0003786_premature_aging | 0.96906223 |
106 | MP0000358_abnormal_cell_content/ | 0.96812356 |
107 | MP0001845_abnormal_inflammatory_respons | 0.95752653 |
108 | MP0004947_skin_inflammation | 0.94542512 |
109 | MP0001533_abnormal_skeleton_physiology | 0.94015340 |
110 | MP0005220_abnormal_exocrine_pancreas | 0.91973406 |
111 | MP0003315_abnormal_perineum_morphology | 0.91476838 |
112 | MP0005410_abnormal_fertilization | 0.91331378 |
113 | MP0005275_abnormal_skin_tensile | 0.90821490 |
114 | MP0002009_preneoplasia | 0.89779545 |
115 | MP0010368_abnormal_lymphatic_system | 0.89265638 |
116 | MP0000566_synostosis | 0.88081694 |
117 | MP0000538_abnormal_urinary_bladder | 0.87543518 |
118 | MP0001986_abnormal_taste_sensitivity | 0.86579903 |
119 | MP0008469_abnormal_protein_level | 0.85737826 |
120 | MP0000609_abnormal_liver_physiology | 0.85682395 |
121 | MP0001542_abnormal_bone_strength | 0.84778198 |
122 | MP0000579_abnormal_nail_morphology | 0.84642129 |
123 | MP0000003_abnormal_adipose_tissue | 0.83367213 |
124 | MP0005390_skeleton_phenotype | 0.82734275 |
125 | MP0001243_abnormal_dermal_layer | 0.81582132 |
126 | MP0009764_decreased_sensitivity_to | 0.80511240 |
127 | MP0003448_altered_tumor_morphology | 0.80506076 |
128 | MP0001663_abnormal_digestive_system | 0.80399195 |
129 | MP0000343_altered_response_to | 0.79985108 |
130 | MP0004133_heterotaxia | 0.79330559 |
131 | MP0002019_abnormal_tumor_incidence | 0.79323213 |
132 | MP0004185_abnormal_adipocyte_glucose | 0.78884001 |
133 | MP0000465_gastrointestinal_hemorrhage | 0.78560604 |
134 | MP0001191_abnormal_skin_condition | 0.76406144 |
135 | MP0001881_abnormal_mammary_gland | 0.75561749 |
136 | MP0000749_muscle_degeneration | 0.75279242 |
137 | MP0003866_abnormal_defecation | 0.75022923 |
138 | MP0001346_abnormal_lacrimal_gland | 0.74569806 |
139 | MP0001764_abnormal_homeostasis | 0.72937572 |
140 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72852757 |
141 | MP0003183_abnormal_peptide_metabolism | 0.72770146 |
142 | MP0002075_abnormal_coat/hair_pigmentati | 0.72394079 |
143 | MP0000377_abnormal_hair_follicle | 0.70843217 |
144 | MP0009697_abnormal_copulation | 0.69979218 |
145 | MP0001919_abnormal_reproductive_system | 0.69634212 |
146 | MP0000767_abnormal_smooth_muscle | 0.69619279 |
147 | MP0010771_integument_phenotype | 0.69262577 |
148 | MP0001851_eye_inflammation | 0.68845766 |
149 | MP0006292_abnormal_olfactory_placode | 0.64488814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Reticulocytopenia (HP:0001896) | 4.83745373 |
2 | Abnormal hemoglobin (HP:0011902) | 4.71822170 |
3 | Cholecystitis (HP:0001082) | 3.59683503 |
4 | Abnormal gallbladder physiology (HP:0012438) | 3.59683503 |
5 | Eczematoid dermatitis (HP:0000976) | 3.47308265 |
6 | Congenital, generalized hypertrichosis (HP:0004540) | 3.40841428 |
7 | Alveolar cell carcinoma (HP:0006519) | 3.30815728 |
8 | Hypertensive crisis (HP:0100735) | 3.26261689 |
9 | Recurrent abscess formation (HP:0002722) | 3.24910818 |
10 | Macrocytic anemia (HP:0001972) | 3.15384016 |
11 | Pallor (HP:0000980) | 3.11529574 |
12 | Increased serum ferritin (HP:0003281) | 3.07959662 |
13 | Abnormal number of erythroid precursors (HP:0012131) | 2.95984740 |
14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.95657785 |
15 | Exertional dyspnea (HP:0002875) | 2.95449287 |
16 | Squamous cell carcinoma (HP:0002860) | 2.87781597 |
17 | Cheilitis (HP:0100825) | 2.87030077 |
18 | Easy fatigability (HP:0003388) | 2.84894940 |
19 | Severe visual impairment (HP:0001141) | 2.82554225 |
20 | Chest pain (HP:0100749) | 2.82169494 |
21 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.81831834 |
22 | Recurrent bacterial skin infections (HP:0005406) | 2.79762653 |
23 | Ventricular tachycardia (HP:0004756) | 2.77612293 |
24 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.72526215 |
25 | Attenuation of retinal blood vessels (HP:0007843) | 2.69934847 |
26 | Chromsome breakage (HP:0040012) | 2.64506797 |
27 | Obstructive lung disease (HP:0006536) | 2.62572610 |
28 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62572610 |
29 | Sparse eyelashes (HP:0000653) | 2.51452306 |
30 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.49984846 |
31 | Thrombocytosis (HP:0001894) | 2.49607734 |
32 | Pulmonary infiltrates (HP:0002113) | 2.48623345 |
33 | Pustule (HP:0200039) | 2.47516636 |
34 | Abnormality of iron homeostasis (HP:0011031) | 2.46967077 |
35 | Recurrent fungal infections (HP:0002841) | 2.45447280 |
36 | Premature graying of hair (HP:0002216) | 2.45357477 |
37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41287048 |
38 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.39308370 |
39 | Myositis (HP:0100614) | 2.37958705 |
40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.34166698 |
41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32789223 |
42 | Lip pit (HP:0100267) | 2.31062231 |
43 | Petechiae (HP:0000967) | 2.30688047 |
44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29899710 |
45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29899710 |
46 | Abnormality of the preputium (HP:0100587) | 2.29335240 |
47 | Myopathic facies (HP:0002058) | 2.29112900 |
48 | Breast hypoplasia (HP:0003187) | 2.26987415 |
49 | Onycholysis (HP:0001806) | 2.26177667 |
50 | Reticulocytosis (HP:0001923) | 2.25838835 |
51 | Woolly hair (HP:0002224) | 2.24521594 |
52 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.22651729 |
53 | Distal lower limb muscle weakness (HP:0009053) | 2.22130153 |
54 | Pendular nystagmus (HP:0012043) | 2.21998018 |
55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.21925924 |
56 | J-shaped sella turcica (HP:0002680) | 2.21711245 |
57 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.19744000 |
58 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.19744000 |
59 | Trismus (HP:0000211) | 2.18693071 |
60 | Absent thumb (HP:0009777) | 2.18465450 |
61 | Aplastic anemia (HP:0001915) | 2.18088962 |
62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.16529577 |
63 | Congenital stationary night blindness (HP:0007642) | 2.15996455 |
64 | Hepatocellular necrosis (HP:0001404) | 2.15700530 |
65 | Stomatitis (HP:0010280) | 2.15696899 |
66 | Nonimmune hydrops fetalis (HP:0001790) | 2.14525648 |
67 | Cholelithiasis (HP:0001081) | 2.12658243 |
68 | Sparse scalp hair (HP:0002209) | 2.10130620 |
69 | Ridged nail (HP:0001807) | 2.09386906 |
70 | Triphalangeal thumb (HP:0001199) | 2.08655740 |
71 | Fatigable weakness (HP:0003473) | 2.08227488 |
72 | Abnormality of the neuromuscular junction (HP:0003398) | 2.08227488 |
73 | Testicular atrophy (HP:0000029) | 2.06578086 |
74 | Meningitis (HP:0001287) | 2.06111276 |
75 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.05900191 |
76 | Agammaglobulinemia (HP:0004432) | 2.05144226 |
77 | Panhypogammaglobulinemia (HP:0003139) | 2.04238345 |
78 | Rough bone trabeculation (HP:0100670) | 2.03923434 |
79 | Alopecia of scalp (HP:0002293) | 2.03573851 |
80 | Unilateral renal agenesis (HP:0000122) | 2.03539377 |
81 | Recurrent skin infections (HP:0001581) | 2.02236308 |
82 | Lipid accumulation in hepatocytes (HP:0006561) | 2.02011166 |
83 | Recurrent viral infections (HP:0004429) | 2.01219326 |
84 | Entropion (HP:0000621) | 2.01152228 |
85 | Dry hair (HP:0011359) | 1.99848178 |
86 | Progressive muscle weakness (HP:0003323) | 1.99590632 |
87 | Increased intramyocellular lipid droplets (HP:0012240) | 1.99227346 |
88 | Hepatic necrosis (HP:0002605) | 1.99171848 |
89 | Oral leukoplakia (HP:0002745) | 1.98805298 |
90 | Prolonged bleeding time (HP:0003010) | 1.97537489 |
91 | Mediastinal lymphadenopathy (HP:0100721) | 1.97107905 |
92 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.97008240 |
93 | Hyperacusis (HP:0010780) | 1.96729826 |
94 | Atelectasis (HP:0100750) | 1.95610570 |
95 | Cellulitis (HP:0100658) | 1.95220988 |
96 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.95191197 |
97 | Chronic otitis media (HP:0000389) | 1.95097011 |
98 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94530166 |
99 | Ocular albinism (HP:0001107) | 1.92327769 |
100 | Increased muscle lipid content (HP:0009058) | 1.91378786 |
101 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.91314199 |
102 | Persistence of primary teeth (HP:0006335) | 1.91163318 |
103 | Increased cerebral lipofuscin (HP:0011813) | 1.90412032 |
104 | Prostate neoplasm (HP:0100787) | 1.90094818 |
105 | Exercise-induced myalgia (HP:0003738) | 1.89297833 |
106 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.88250972 |
107 | Reduced antithrombin III activity (HP:0001976) | 1.87260007 |
108 | Abnormality of nail color (HP:0100643) | 1.87026509 |
109 | Nail dystrophy (HP:0008404) | 1.85087268 |
110 | Inflammation of the large intestine (HP:0002037) | 1.84995709 |
111 | Ragged-red muscle fibers (HP:0003200) | 1.84268470 |
112 | Urticaria (HP:0001025) | 1.84137725 |
113 | Poikiloderma (HP:0001029) | 1.82200536 |
114 | Granulocytopenia (HP:0001913) | 1.82069444 |
115 | Abnormality of the axillary hair (HP:0100134) | 1.81969414 |
116 | Abnormality of secondary sexual hair (HP:0009888) | 1.81969414 |
117 | Increased IgE level (HP:0003212) | 1.81503045 |
118 | Natal tooth (HP:0000695) | 1.81349812 |
119 | Sudden death (HP:0001699) | 1.81026984 |
120 | Renal Fanconi syndrome (HP:0001994) | 1.80974007 |
121 | Abnormal gallbladder morphology (HP:0012437) | 1.80823541 |
122 | Periodontitis (HP:0000704) | 1.80494182 |
123 | Retinal dysplasia (HP:0007973) | 1.79945025 |
124 | Abnormality of T cells (HP:0002843) | 1.79492617 |
125 | Abnormality of T cell physiology (HP:0011840) | 1.79386201 |
126 | Abnormal protein glycosylation (HP:0012346) | 1.78908547 |
127 | Abnormal glycosylation (HP:0012345) | 1.78908547 |
128 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.78908547 |
129 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.78908547 |
130 | Right ventricular cardiomyopathy (HP:0011663) | 1.78479901 |
131 | Erythema (HP:0010783) | 1.77704228 |
132 | IgM deficiency (HP:0002850) | 1.77653581 |
133 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77539155 |
134 | Respiratory difficulties (HP:0002880) | 1.77375495 |
135 | Rhabdomyolysis (HP:0003201) | 1.76820485 |
136 | Areflexia of lower limbs (HP:0002522) | 1.76123891 |
137 | Premature loss of primary teeth (HP:0006323) | 1.75998761 |
138 | Patellar aplasia (HP:0006443) | 1.75936366 |
139 | Lipoatrophy (HP:0100578) | 1.75556593 |
140 | Seborrheic dermatitis (HP:0001051) | 1.75043741 |
141 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74638947 |
142 | Emphysema (HP:0002097) | 1.74081880 |
143 | Vacuolated lymphocytes (HP:0001922) | 1.73946557 |
144 | Type I transferrin isoform profile (HP:0003642) | 1.73885245 |
145 | Lymphangioma (HP:0100764) | 1.73761485 |
146 | Gingivitis (HP:0000230) | 1.73433507 |
147 | Pulmonary fibrosis (HP:0002206) | 1.73090081 |
148 | Clubbing of toes (HP:0100760) | 1.73031066 |
149 | Acute hepatic failure (HP:0006554) | 1.72694606 |
150 | Gastrointestinal inflammation (HP:0004386) | 1.72165782 |
151 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71434759 |
152 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71434759 |
153 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71434759 |
154 | Gastrointestinal infarctions (HP:0005244) | 1.71269799 |
155 | Hypoplasia of the uterus (HP:0000013) | 1.70667523 |
156 | Abnormality of lateral ventricle (HP:0030047) | 1.70137995 |
157 | Amniotic constriction ring (HP:0009775) | 1.69175913 |
158 | Abnormality of placental membranes (HP:0011409) | 1.69175913 |
159 | Abnormality of the prostate (HP:0008775) | 1.68761168 |
160 | Abnormality of chromosome stability (HP:0003220) | 1.68147079 |
161 | Sparse lateral eyebrow (HP:0005338) | 1.68031323 |
162 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.67814454 |
163 | Ureteral stenosis (HP:0000071) | 1.66236264 |
164 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.66124125 |
165 | Myoglobinuria (HP:0002913) | 1.66104921 |
166 | Autoimmune hemolytic anemia (HP:0001890) | 1.65941628 |
167 | Muscle fiber atrophy (HP:0100295) | 1.65531446 |
168 | Progressive microcephaly (HP:0000253) | 1.65036089 |
169 | Premature rupture of membranes (HP:0001788) | 1.64360889 |
170 | Plantar hyperkeratosis (HP:0007556) | 1.63416230 |
171 | Myelodysplasia (HP:0002863) | 1.63297574 |
172 | Skin ulcer (HP:0200042) | 1.63232123 |
173 | Abnormality of macrophages (HP:0004311) | 1.63198600 |
174 | Ependymoma (HP:0002888) | 1.62939879 |
175 | Depressed nasal ridge (HP:0000457) | 1.62622702 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 3.71809172 |
2 | TLK1 | 3.50539700 |
3 | IRAK3 | 3.27152028 |
4 | VRK2 | 3.25551335 |
5 | IRAK4 | 3.14027355 |
6 | TAF1 | 3.12763934 |
7 | SMG1 | 2.98799594 |
8 | EIF2AK1 | 2.87588805 |
9 | PIM2 | 2.59384770 |
10 | MUSK | 2.31913241 |
11 | MAP4K1 | 2.26293438 |
12 | SIK1 | 2.24946825 |
13 | MST1R | 2.23256639 |
14 | NEK9 | 2.19637361 |
15 | TRIB3 | 2.13781153 |
16 | PRKCI | 2.08701560 |
17 | TEC | 2.06075932 |
18 | BLK | 1.95527962 |
19 | BUB1 | 1.89653186 |
20 | BCKDK | 1.87075174 |
21 | EPHA2 | 1.82476291 |
22 | TXK | 1.72262318 |
23 | NLK | 1.68589263 |
24 | FLT3 | 1.65464811 |
25 | TIE1 | 1.63586780 |
26 | MAP3K14 | 1.59173047 |
27 | IRAK1 | 1.53982489 |
28 | EEF2K | 1.53163500 |
29 | MAPKAPK3 | 1.43171124 |
30 | NUAK1 | 1.42648578 |
31 | IKBKE | 1.35473814 |
32 | RPS6KA4 | 1.35011794 |
33 | PRKD2 | 1.34773618 |
34 | IKBKB | 1.33193006 |
35 | ZAK | 1.30482884 |
36 | MAP3K11 | 1.28830642 |
37 | TBK1 | 1.26308152 |
38 | MAP3K3 | 1.23752339 |
39 | KDR | 1.23414408 |
40 | IRAK2 | 1.22359491 |
41 | GRK6 | 1.21609239 |
42 | EPHB1 | 1.21245261 |
43 | CDK8 | 1.19594791 |
44 | JAK3 | 1.17466195 |
45 | EIF2AK2 | 1.15382981 |
46 | ZAP70 | 1.12031715 |
47 | PIM1 | 1.09948997 |
48 | TYK2 | 1.09872157 |
49 | CSK | 1.09544796 |
50 | VRK1 | 1.07805213 |
51 | BTK | 1.07728120 |
52 | KIT | 1.07037773 |
53 | STK10 | 1.07000173 |
54 | DMPK | 1.06115460 |
55 | WEE1 | 1.05710998 |
56 | TAOK3 | 1.05049992 |
57 | TGFBR2 | 1.04973755 |
58 | CCNB1 | 1.03991321 |
59 | TRPM7 | 1.03755517 |
60 | SIK3 | 1.02224269 |
61 | PBK | 1.02102550 |
62 | DYRK1B | 1.01953325 |
63 | NME1 | 0.99490891 |
64 | TNK2 | 0.98400301 |
65 | TESK2 | 0.98250663 |
66 | WNK4 | 0.97553031 |
67 | TESK1 | 0.97011837 |
68 | FES | 0.96751747 |
69 | PRPF4B | 0.95037010 |
70 | MAP2K3 | 0.94778739 |
71 | SIK2 | 0.91658318 |
72 | ICK | 0.90970722 |
73 | SRPK1 | 0.90858071 |
74 | PIK3CG | 0.90562683 |
75 | CLK1 | 0.89645672 |
76 | RPS6KB2 | 0.88605079 |
77 | MST4 | 0.88075135 |
78 | STK4 | 0.87873148 |
79 | MKNK2 | 0.86308547 |
80 | RPS6KA2 | 0.85657318 |
81 | PKN2 | 0.85053294 |
82 | CAMK1D | 0.84385867 |
83 | AURKB | 0.83042090 |
84 | DYRK3 | 0.80896518 |
85 | PLK4 | 0.79804800 |
86 | MAP3K1 | 0.79349690 |
87 | BMX | 0.77914553 |
88 | CDK7 | 0.76737796 |
89 | ATR | 0.76649684 |
90 | EIF2AK3 | 0.74897565 |
91 | TTK | 0.73726185 |
92 | TTN | 0.72695953 |
93 | GRK7 | 0.71108471 |
94 | AURKA | 0.70277532 |
95 | LCK | 0.70172872 |
96 | OBSCN | 0.69612041 |
97 | CHUK | 0.69057650 |
98 | STK16 | 0.68800871 |
99 | BRSK2 | 0.67714709 |
100 | DAPK1 | 0.66654575 |
101 | YES1 | 0.66579612 |
102 | MATK | 0.66359910 |
103 | NEK2 | 0.65534940 |
104 | PTK6 | 0.65149439 |
105 | MAP3K5 | 0.64221797 |
106 | CDK9 | 0.62942494 |
107 | RIPK4 | 0.62710402 |
108 | GRK1 | 0.62639301 |
109 | LYN | 0.62002295 |
110 | ADRBK2 | 0.61884292 |
111 | TAOK1 | 0.60997910 |
112 | MAP3K8 | 0.60783815 |
113 | PLK1 | 0.60608336 |
114 | TAOK2 | 0.59653747 |
115 | CSF1R | 0.58869009 |
116 | CHEK2 | 0.58443645 |
117 | MYLK | 0.57992069 |
118 | MAPK11 | 0.57842333 |
119 | EPHA3 | 0.57787312 |
120 | MAP2K2 | 0.56424439 |
121 | CDK6 | 0.56002999 |
122 | CDK12 | 0.55837619 |
123 | ACVR1B | 0.55096204 |
124 | ITK | 0.54558860 |
125 | RPS6KC1 | 0.54390069 |
126 | RPS6KL1 | 0.54390069 |
127 | RPS6KA6 | 0.53437641 |
128 | LIMK1 | 0.53436126 |
129 | MAP2K6 | 0.53405391 |
130 | SYK | 0.53158899 |
131 | MAPK4 | 0.52834718 |
132 | LMTK2 | 0.51885635 |
133 | MKNK1 | 0.51746611 |
134 | PTK2B | 0.49235556 |
135 | RPS6KA5 | 0.47638254 |
136 | MARK3 | 0.47112727 |
137 | FGFR3 | 0.46920427 |
138 | MAPKAPK2 | 0.45381710 |
139 | HCK | 0.45100324 |
140 | JAK1 | 0.45036947 |
141 | MAPKAPK5 | 0.43808663 |
142 | TGFBR1 | 0.43187817 |
143 | MTOR | 0.41877392 |
144 | ERN1 | 0.40371269 |
145 | MET | 0.39286221 |
146 | CDK4 | 0.38543910 |
147 | PAK4 | 0.38472101 |
148 | PHKG2 | 0.34684031 |
149 | PHKG1 | 0.34684031 |
150 | ARAF | 0.31165195 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 5.25011787 |
2 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.90815109 |
3 | Homologous recombination_Homo sapiens_hsa03440 | 3.02068443 |
4 | DNA replication_Homo sapiens_hsa03030 | 2.87420234 |
5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.46837006 |
6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.36832508 |
7 | RNA polymerase_Homo sapiens_hsa03020 | 2.35580713 |
8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.34077970 |
9 | Mismatch repair_Homo sapiens_hsa03430 | 2.30500246 |
10 | Base excision repair_Homo sapiens_hsa03410 | 2.15828255 |
11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.12959929 |
12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94980306 |
13 | Protein export_Homo sapiens_hsa03060 | 1.91350116 |
14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.89918325 |
15 | Galactose metabolism_Homo sapiens_hsa00052 | 1.89763469 |
16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.81734111 |
17 | Spliceosome_Homo sapiens_hsa03040 | 1.69845807 |
18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.67668228 |
19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.66581847 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65285298 |
21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62711867 |
22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.60276688 |
23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60010049 |
24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59698471 |
25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.57570389 |
26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.54380859 |
27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53210436 |
28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50076208 |
29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.42264503 |
30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.40413363 |
31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.40167553 |
32 | Measles_Homo sapiens_hsa05162 | 1.39578360 |
33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36960552 |
34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.29445924 |
35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29143079 |
36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26671248 |
37 | Proteasome_Homo sapiens_hsa03050 | 1.26128333 |
38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.23490705 |
39 | Cell cycle_Homo sapiens_hsa04110 | 1.21965644 |
40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21152803 |
41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18379937 |
42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11317381 |
43 | RNA degradation_Homo sapiens_hsa03018 | 1.10117053 |
44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08989874 |
45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07553955 |
46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06418565 |
47 | Legionellosis_Homo sapiens_hsa05134 | 1.05194568 |
48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03968050 |
49 | Pertussis_Homo sapiens_hsa05133 | 1.03514475 |
50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03352826 |
51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02905094 |
52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01581570 |
53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00864411 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00010699 |
55 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99284931 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98189542 |
57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98007152 |
58 | Influenza A_Homo sapiens_hsa05164 | 0.97310290 |
59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94498501 |
60 | RNA transport_Homo sapiens_hsa03013 | 0.94209418 |
61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93946477 |
62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93441215 |
63 | Lysosome_Homo sapiens_hsa04142 | 0.93104233 |
64 | Malaria_Homo sapiens_hsa05144 | 0.92789683 |
65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92322771 |
66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89291124 |
67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89248345 |
68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89239817 |
69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87851073 |
70 | Apoptosis_Homo sapiens_hsa04210 | 0.87590771 |
71 | Shigellosis_Homo sapiens_hsa05131 | 0.82083749 |
72 | Purine metabolism_Homo sapiens_hsa00230 | 0.80303255 |
73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79783790 |
74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78872610 |
75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78764976 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78698881 |
77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77971628 |
78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77809685 |
79 | Hepatitis B_Homo sapiens_hsa05161 | 0.77764754 |
80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76177172 |
81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74185150 |
82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73808916 |
83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72902390 |
84 | Allograft rejection_Homo sapiens_hsa05330 | 0.71879994 |
85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71215210 |
86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70919223 |
87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69854194 |
88 | Lysine degradation_Homo sapiens_hsa00310 | 0.64377665 |
89 | Tuberculosis_Homo sapiens_hsa05152 | 0.64232422 |
90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64067674 |
91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62898615 |
92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60659014 |
93 | Hepatitis C_Homo sapiens_hsa05160 | 0.60567980 |
94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59907539 |
95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59102212 |
96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58831948 |
97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56845347 |
98 | Bladder cancer_Homo sapiens_hsa05219 | 0.56769420 |
99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56557446 |
100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55210038 |
101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54740295 |
102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54503351 |
103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54420665 |
104 | Phototransduction_Homo sapiens_hsa04744 | 0.53471977 |
105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53453029 |
106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51461607 |
107 | Platelet activation_Homo sapiens_hsa04611 | 0.51058756 |
108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50962910 |
109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50594892 |
110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49628728 |
111 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47448865 |
112 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47398977 |
113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47264729 |
114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45813092 |
115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45579470 |
116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44849750 |
117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44471619 |
118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44340703 |
119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43910181 |
120 | Insulin resistance_Homo sapiens_hsa04931 | 0.43648184 |
121 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43523968 |
122 | Salmonella infection_Homo sapiens_hsa05132 | 0.43236168 |
123 | Asthma_Homo sapiens_hsa05310 | 0.41964364 |
124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40311080 |
125 | ABC transporters_Homo sapiens_hsa02010 | 0.38737536 |
126 | Adherens junction_Homo sapiens_hsa04520 | 0.38454783 |
127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38003545 |
128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37141274 |
129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36916866 |
130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36787153 |
131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36549882 |
132 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34657362 |
133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34046346 |
134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33669484 |
135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33359150 |
136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32823565 |
137 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32427596 |
138 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31146568 |